Pancreatic Cancer

Laparoscopic pancreaticoduodenectomy had similar short-term outcomes compared with open surgery among patients with pancreatic ductal adenocarcinoma, according to study results published in JAMA Surgery.

A phase 1/phase 2 study will evaluate the efficacy and safety of azeliragon for patients refractory to first-line treatment for metastatic pancreatic cancer.

Researchers at The University of Texas MD Anderson Cancer Center have made improvements to hospital care pathways that reduced opioid use by 50% after pancreatic cancer surgery.

Susan Tsai, MD, has been appointed chief of the division of surgical oncology at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

New diagnoses for six of the most common cancer types sharply declined in the U.S. in early 2020 — along with the volume of pathology reports — largely due to the start of the COVID-19 pandemic, according to data released by NCI.

Researchers at Harvard Medical School and University of Copenhagen developed an artificial intelligence tool with the potential to identify people at greatest risk for pancreatic cancer up to 3 years before diagnosis.

Use of any benzodiazepine appeared associated with reduced risk for pancreatic cancer-related death, according to study results published in Clinical Cancer Research.

Surgery appeared underutilized for patients with pancreatic ductal adenocarcinoma, according to study findings published in Journal of Surgical Oncology.

Abstracts of randomized phase 3 clinical trials in gastrointestinal oncology frequently use subjective minimizing language to characterize serious toxicities, according to results of a systematic review presented at ASCO Annual Meeting.

Identification of inherited genetic mutations that elevate cancer risk and may be susceptible to targeted therapies has transformed oncology care.